Medicine Supply Notification: Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials
TO NOTE: This MSN is the one of two covering supply issues with insulin vials. MSN/2024/057 issued on 20/05/24 covered Humulin® S (insulin soluble human). This MSN (MSN/2024/072) covers Humalog® (insulin lispro). CAUTION: These products have similar sounding names and appropriate risk minimisation strategies should be implemented to ensure actions are carried out for specific products
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials
MSN/2024/072
Tier 2 – medium impact
Date of issue: 18th June 2024
- Humalog® (insulin lispro) 100units/ml 10ml vials will be out of stock from early-June 2024 until early July 2024.
- NovoRapid® and Trurapi® (insulin aspart) 100units/ml 10ml vials remain available.
- Admelog® and Lyumjev® (insulin lispro) 100units/ml 10ml vials remain available, however cannot support an increase in demand.
- Fiasp® (insulin aspart) 100units/ml 10ml vials remain available, however cannot support an increase in demand
- Humalog® 100units/ml 3ml cartridges and Humalog KwikPen® and Junior KwikPen® 100 units/ml 3ml pre-filled pens remain available and can support increased demand.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
